Electromed, Inc.
As of Oct 22, 2026, Electromed is in Stage 4, the downtrend phase, now in its first week (since Oct 16, 2026). It closed at $26.87, 42.0% below its 52-week high and below its 200-day average, which is falling.
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patient… More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Is ELMD early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
ELMD among Medical Devices41st of 141 by relative strength
All 141 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | TXG | Stage 2 · wk 48 | 99 | −7.8% |
| 2 | RCEL | Stage 2 · wk 13 | 98 | +40.8% |
| 3 | BFLY | Stage 2 · wk 26 | 98 | −26.0% |
| 4 | HAE | Stage 2 · wk 17 | 96 | +8.7% |
| 5 | GKOS | Stage 2 · wk 25 | 96 | +15.1% |
| 6 | AXGN | Stage 3 · wk 2 | 95 | −15.3% |
| 7 | NEOG | Stage 2 · wk 14 | 95 | −11.7% |
| 8 | BVS | Stage 2 · wk 15 | 95 | +10.5% |
| …41 | ELMD | Stage 4 · wk 1 | 61 | −2.5% |
Electromed: quick answers
What stage is Electromed in?
As of Oct 22, 2026, Electromed (ELMD) is in Stage 4, the downtrend phase. It entered Stage 4 on Oct 16, 2026 and is in its first week there. What the four stages mean
Is Electromed in an uptrend?
No. Electromed is in a Stage 4 downtrend. It trades 14.2% below its 200-day average, which is falling.
How far is Electromed from its 52-week high?
Electromed closed at $26.87 on Oct 22, 2026, 42.0% below its 52-week high of $46.31. Its 52-week low is $23.15.
How has Electromed performed over the past year?
As of Oct 22, 2026, Electromed is up 8.4% over the past year and down 1.9% so far in 2026.
Which sector and industry is Electromed in?
Electromed is in the Medical Devices industry, part of the Health Care sector.
About this companyHealth Care· Medical Devices
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients in the United States and internationally. The company provides SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy, muscular dystrophies, amyotrophic lateral sclerosis, and post-surgical complications; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.